Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
+64 20 4133 5102
Email
michael.garelja@otago.ac.nz
Position
Research Fellow
Department
Department of Pharmacology and Toxicology
Qualifications
PhD
Research summary
Molecular basis of migraine
Teaching
  • PHAL303, PHAL421, PHAL423, PHAL431
  • Molecular pharmacology of GPCRs
  • Neuroscience
Memberships
  • OMSRS Editorial Board
  • Division of Health Sciences Early and Mid-Career Researchers Group
  • Biomedical Research Facility Users Group

Research

Michael Garelja obtained a PhD in Biological Sciences from the University of Auckland in 2020. His PhD work focused on the molecular pharmacology of adrenomedullin, a hormone involved in cardiovascular development and maintenance.

In late 2020 Michael moved to the University of Otago, to begin work on calcitonin gene-related peptide (CGRP), a hormone linked to migraine. Michael has recently completed a First Fellowship, awarded by the Neurological Foundation of New Zealand, in which he focused on understanding the distribution of CGRP, its related peptides, and their receptors in the context of migraine.

Working in the lab of his mentor, Professor Debbie Hay, Michael uses a range of techniques to investigate the molecular basis of migraine, including molecular biology, microscopy, and pharmacological signalling assays. These techniques are also applied to research outside of migraine, such as diabetes and the evolution of GPCRs.

Publications

Garelja, M. L., Alexander, T. I., Walker, C. S., & Hay, D. L. (2024). Extracellular bimolecular fluorescence complementation for investigating membrane protein dimerization: A proof of concept using class B GPCRs. Bioscience Reports. Advance online publication. doi: 10.1042/bsr20240449 Journal - Research Article

Babych, M., Garelja, M. L., Nguyen, P. T., Hay, D. L., & Bourgault, S. (2024). Converting the amyloidogenic islet amyloid polypeptide into a potent nonaggregating peptide ligand by side chain-to-side chain macrocyclization. Journal of the American Chemical Society. Advance online publication. doi: 10.1021/jacs.4c05297 Journal - Research Article

Hay, D., Rizwan, M., Forrester, L., Rees, T., Rea, B., Sowers, L., … Garelja, M. (2024). Subcutaneous administration of calcitonin-gene related peptide or amylin induces non-evoked pain in female rats. Headache, 64(Suppl. 1), (pp. 13). doi: 10.1111/head.14716 Conference Contribution - Published proceedings: Abstract

Hay, D., Nimick, M., Garelja, M., Alexander, T., Walker, C., & Banerjee, P. (2024). Pharmacological characterization of ubrogepant and atogepant in cAMP assays at human, rat and mouse calcitonin family receptors in transfected cells. Headache, 64(Suppl. 1), (pp. 11-12). doi: 10.1111/head.14716 Conference Contribution - Published proceedings: Abstract

Hay, D., Alexander, T., Nimick, M., Garelja, M., Walker, C., & Banerjee, P. (2024). Antagonism by ubrogepant and atogepant of agonist-mediated human CGRP receptor β-arrestin recruitment and internalization in transfected cells. Headache, 64(Suppl. 1), (pp. 3-4). doi: 10.1111/head.14716 Conference Contribution - Published proceedings: Abstract

Back to top